Effect of ursodeoxycholic acid on gallstone formation after bariatric surgery: An updated meta‐analysis. Issue 6 (27th April 2022)

• Record Type: Journal Article
• Authors: Ying, Jingjing; Dai, Senjie; Fu, Rongrong; Hong, Jiaze; Dai, Chenglong; Jin, Qiong
• Is Part Of: Obesity. Volume 30:Issue 6(2022)
• Page Start: 1170
• Page End: 1180
• Publication Date: 2022-04-27
• Subjects: Obesity -- Periodicals; 616.398005
• DOI: 10.1002/oby.23427
• Languages: English
• ISSNs: 1930-7381

Abstract

Abstract: Objective: Bariatric surgery increases the risk of postoperative gallstone formation. Many studies have proposed ursodeoxycholic acid (UDCA) as a preventive agent for postoperative gallstone formation. This study aimed to investigate the effect of UDCA on gallstone formation after bariatric surgery in patients without preoperative gallstones. Methods: PubMed, the Web of Science, the Cochrane Library, and EBSCO were searched for articles assessing the effect of UDCA on gallstone formation after bariatric surgery. The outcome was the incidence of postoperative gallstones. Odds ratios were used to assess dichotomous variables, and random‐effects models were used for statistical analyses. Results: A total of 18 studies including 4, 827 participants met the inclusion criteria. The statistical results showed that the incidence of gallstones in the UDCA group was significantly lower than in the control group. Furthermore, the occurrence of symptomatic gallstones and cholecystectomy was significantly reduced. Conclusions: In patients without preoperative gallstones, UDCA can effectively prevent the formation of gallstones after bariatric surgery. In addition, UDCA can significantly reduce the occurrence of symptomatic gallstones and the risk of postoperative cholecystectomy. Doses of 500 to 600 mg/d can be used as a measure to prevent postoperative gallstone formation.